AXSM
Axsome Therapeutics, Inc.
+1.06 (+0.50%)213.03USD200K成交股數11.2B市值–本益比(近四季)14.4股價營收比+45.5%營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 218M+80% | 191M+61% | 171M+63% | 150M+72% | 121M+62% | 119M+105% | 105M+124% | 87.2M-8% | 75.0M | 57.8M | 46.7M | 94.6M |
| 營業成本 | 13.6M | 14.7M | 11.9M | 13.4M | 9.8M | 10.5M | 8.4M | 8.1M | 6.3M | 6.5M | 4.6M | 7.6M |
| 毛利 | 205M+83% | 176M+63% | 159M+65% | 137M+73% | 112M+63% | 108M+111% | 96.3M+129% | 79.1M-9% | 68.7M | 51.3M | 42.1M | 87.0M |
| 毛利率 | 93.8% | 92.3% | 93.0% | 91.0% | 91.9% | 91.1% | 91.9% | 90.8% | 91.6% | 88.7% | 90.2% | 92.0% |
| 研發費用 | 46.2M | 52.7M | 40.2M | 49.5M | 44.8M | 55.0M | 45.4M | 49.9M | 36.8M | 28.8M | 20.6M | 17.8M |
| 銷售管理費用 | 208M | 185M | 150M | 130M | 121M | 113M | 95.6M | 104M | 99.0M | 83.2M | 78.9M | 74.2M |
| 營業利益 | −49.6M-13% | −63.4M-13% | −46.1M-26% | −36.7M-53% | −57.0M-15% | −72.6M+17% | −62.6M-4% | −78.0M+1124% | −67.3M | −62.1M | −65.1M | −6.4M |
| 營業利益率 | -22.7% | -33.1% | -27.0% | -24.5% | -46.9% | -61.1% | -59.8% | -89.5% | -89.7% | -107.5% | -139.3% | -6.7% |
| 稅後淨利 | −51.3M-14% | −64.5M-14% | −47.2M-27% | −48.0M-40% | −59.4M-13% | −74.9M+20% | −64.6M-4% | −79.3M+607% | −68.4M | −62.2M | −67.2M | −11.2M |
| 淨利率 | -23.5% | -33.8% | -27.6% | -32.0% | -48.9% | -63.1% | -61.7% | -91.0% | -91.1% | -107.6% | -143.8% | -11.9% |
| 稀釋 EPS | -0.99-19% | -1.26-18% | -0.94-30% | -0.97-42% | -1.22-15% | -1.54+17% | -1.34-13% | -1.67+542% | -1.44 | -1.32 | -1.54 | -0.26 |
| 稀釋股數 | 51.8M | 51.2M | 50.0M | 49.4M | 48.9M | 47.9M | 48.1M | 47.6M | 47.4M | 47.1M | 43.7M | 43.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 320M | 305M | 325M | 303M | 301M | 315M | 327M | 316M | 331M | 417M | 437M | 247M |
| 應收帳款 | 277M | 251M | 197M | 199M | 161M | 142M | 124M | 120M | 101M | 78.4M | 67.4M | 44.8M |
| 存貨 | 37.9M | 31.5M | 23.8M | 18.4M | 16.3M | 15.7M | 14.3M | 15.2M | 15.6M | 10.0M | 9.3M | 7.9M |
| 總資產 | 761M | 714M | 669M | 640M | 597M | 568M | 561M | 548M | 546M | 601M | 612M | 389M |
| 有息負債 | 118M | 118M | 118M | 118M | 181M | 181M | 180M | 179M | 179M | 177M | 177M | 148M |
| 總負債 | 678M | 659M | 596M | 567M | 543M | 511M | 469M | 445M | 402M | 331M | 333M | 277M |
| 股東權益 | 83.3M | 54.6M | 73.7M | 73.1M | 53.2M | 57.0M | 92.9M | 103M | 144M | 270M | 279M | 112M |
| 負債比 | 89.1% | 92.4% | 89.0% | 88.6% | 91.1% | 90.0% | 83.5% | 81.2% | 73.6% | 55.1% | 54.4% | 71.3% |
| 淨現金(現金 − 有息負債) | 202M | 187M | 208M | 185M | 120M | 135M | 147M | 136M | 153M | 239M | 260M | 98.9M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −20.7M | – | – | −43.4M-19% | – | – | – | −53.5M | – | – | −5.8M |
| 資本支出 | – | 121K | – | – | 338K | – | – | – | 98K | – | – | 71K |
| 自由現金流 | – | −20.8M | – | – | −43.7M-18% | – | – | – | −53.6M | – | – | −5.9M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -10.9% | – | – | -36.0% | – | – | – | -71.4% | – | – | -6.2% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 638M
| 產品 | 634M | 99.3% | +66.1% |
|---|---|---|---|
| Royalty And Milestone Revenue | 4.7M | 0.7% | +17.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 638M | +65.5% | −183M | -28.7% | -3.68 | −93.9M |
| FY2024 | 386M | +42.5% | −287M | -74.5% | -5.99 | −129M |
| FY2023 | 271M | +440.8% | −239M | -88.4% | -5.27 | −146M |
| FY2022 | 50.0M | – | −187M | -374.0% | -4.60 | −117M |
| FY2021 | – | – | −130M | –% | -3.47 | −109M |
| FY2020 | – | – | −103M | –% | -2.77 | −78.5M |
| FY2019 | – | – | −68.3M | –% | -2.01 | −46.4M |
| FY2018 | – | – | −31.0M | –% | -1.15 | −30.1M |